AU5198186A - Method for using Musculoskeletal relaxants - Google Patents

Method for using Musculoskeletal relaxants

Info

Publication number
AU5198186A
AU5198186A AU51981/86A AU5198186A AU5198186A AU 5198186 A AU5198186 A AU 5198186A AU 51981/86 A AU51981/86 A AU 51981/86A AU 5198186 A AU5198186 A AU 5198186A AU 5198186 A AU5198186 A AU 5198186A
Authority
AU
Australia
Prior art keywords
relaxants
musculoskeletal
musculoskeletal relaxants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU51981/86A
Other versions
AU582513B2 (en
Inventor
Eugene M. Laska
Carole E. Siegel
Abraham Sunshine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU5198186A publication Critical patent/AU5198186A/en
Application granted granted Critical
Publication of AU582513B2 publication Critical patent/AU582513B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU51981/86A 1984-12-26 1985-11-27 Method for using musculoskeletal relaxants Ceased AU582513B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US68638084A 1984-12-26 1984-12-26
US68637784A 1984-12-26 1984-12-26
US686380 1984-12-26
US686377 1984-12-26

Publications (2)

Publication Number Publication Date
AU5198186A true AU5198186A (en) 1986-07-22
AU582513B2 AU582513B2 (en) 1989-03-23

Family

ID=27103788

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51981/86A Ceased AU582513B2 (en) 1984-12-26 1985-11-27 Method for using musculoskeletal relaxants

Country Status (4)

Country Link
EP (1) EP0205492A1 (en)
AU (1) AU582513B2 (en)
CA (1) CA1261753A (en)
WO (1) WO1986003681A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2735369B1 (en) * 1995-06-13 1997-07-11 Synthelabo PHARMACEUTICAL COMPOSITIONS BASED ON SODIUM SALT OF DICLOFENAC AND THIOCOLCHICOSIDE
AU3990895A (en) * 1995-12-05 1997-06-27 Adcock Ingram Limited Pharmaceutical composition comprising a skeletal muscle relaxant, a non-steroidal antiinflammatory agent and an analgesic
US6506785B2 (en) * 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
HUP9802716A3 (en) * 1998-11-25 2000-08-28 Chinoin Gyogyszer Es Vegyeszet Pharmaceutical composition of analgesic activity
US20040204413A1 (en) * 2001-01-26 2004-10-14 Joaquina Faour Pharmaceutical compositions containing a COX-II inhibitor and a muscle relaxant
US6562980B1 (en) * 2002-08-19 2003-05-13 Yung Shin Pharma Ind. Co., Ltd. Method for producing 5-aryloxymethyl-2-oxazolidinones
MXPA05010506A (en) * 2005-09-29 2007-03-28 Leopoldo Espinosa Abdala Pharmaceutical form for the treatment of patients with acute cases and exacerbations of rheumatoid arthritis and related acute disorders.
WO2008054188A1 (en) * 2006-10-30 2008-05-08 Farmacéuticos Rayere, S.A. Synergistic pharmaceutical composition comprising lysine clonixinate and carisoprodol
WO2008109018A1 (en) * 2007-03-02 2008-09-12 Meda Pharmaceuticals Inc. Compositions comprising carisoprodol and methods of use thereof
TR200703092A1 (en) 2007-05-08 2008-12-22 SANOVEL �LA� SAN. VE TiC. A.�. Flurbiprofen and muscle relaxant combinations
TR200708925A1 (en) * 2007-12-26 2009-07-21 Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ Combinations of flurbiprofen and muscle relaxants for controlled release
GB2478931B (en) * 2010-03-23 2013-06-12 John Paul Kelly Use of caffeine and aspirin in synergistic amounts for improving performance in sporting activity
BRPI1103205A2 (en) * 2011-06-03 2014-02-25 Eurofarma Lab Ltda ORAL PHARMACEUTICAL COMPOSITION AND USE OF ORAL PHARMACEUTICAL COMPOSITION
ES2582878T3 (en) 2013-09-12 2016-09-15 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical formulation comprising a combination of a muscle relaxant and an analgesic
US20170189374A1 (en) 2014-07-21 2017-07-06 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Zaltoprofen and muscle relaxant combinations
CA2994752A1 (en) * 2015-08-05 2017-02-09 Synergistic Therapeutics, Llc Topical analgesic lotion
DE102020106223A1 (en) 2020-03-06 2021-09-09 Mohammad Amin Jahan Panah Pain medication
DE102019112208B4 (en) * 2019-05-09 2021-10-28 Mohammad Amin Jahan Panah Pain medication
DE112020002320A5 (en) 2019-05-09 2022-01-27 Mohammad Amin Jahan Panah pain medication

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486436A (en) * 1982-07-22 1984-12-04 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4522826A (en) * 1984-02-08 1985-06-11 Richardson-Vicks Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same

Also Published As

Publication number Publication date
CA1261753A (en) 1989-09-26
EP0205492A1 (en) 1986-12-30
AU582513B2 (en) 1989-03-23
WO1986003681A1 (en) 1986-07-03

Similar Documents

Publication Publication Date Title
GB8525769D0 (en) Optical method
GB8508253D0 (en) Locomotion-command method
GB8525099D0 (en) Enzyme-granulating method
AU620002B2 (en) Pressure-controlling method
AU5198186A (en) Method for using Musculoskeletal relaxants
AU3881785A (en) Anordning vid tryckalstrare for vatska
AU578701B2 (en) Grouting method - chemical method
AU555566B2 (en) Woodturning tool
AU572766B2 (en) Filling method
AU3884185A (en) Anordning for odling av plantor jamte forfarande for framstallning av en sadan anordning
AU576355B2 (en) Form creating system
AU586657B2 (en) Feeder-breaker apparatus
AU1856788A (en) Activation method
AU4299685A (en) Ekstra solbrem til bil
AU4086485A (en) Stereocontrolled acetoxyazetidinone process
GB2160562B (en) Ground-freezing method
AU8069787A (en) Insect-proofing method
AU3884085A (en) Forfarande for odling av plantor
AU3835185A (en) Forfarande for framstallning av torkat potatismos
AU2647784A (en) Impact-torque tool
DE3571215D1 (en) Milling method
AU4964085A (en) Kraftpaket for uppvarmning medelst mikrovagsenergi
AU570290B2 (en) Cladding
AU581287B2 (en) Method for fitting ski-boots
BG50210A1 (en) Waterworking method